Showing results (171-180 of 278) with videos related to
Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcomeJeffrey A Sosman, Joseph M Unger, P-Y Liu, et al.Frontiers in Psychiatry|July 29, 2024
Deep brain stimulation for the treatment of substance use disorders: a promising approach requiring cautionJoseph T Sakai, Jody Tanabe, Sharonya Battula, et al.Journal of Neural Engineering|July 3, 2026
Mapping neural representations of fine and gross upper-limb movements across dorsoventral subthalamic nucleus subregions in Parkinson's diseaseErin Michele Radcliffe, Morgan K Hampton, Hayley A Granberg, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 23, 2024
Sleep macro-architecture in patients with Parkinson's disease does not change during the first night of neurostimulation in a pilot studyRig Das, Stephen V Gliske, Leslie C West, et al.Journal of the American Academy of Dermatology|November 6, 2017
Merkel cell carcinoma: Current US incidence and projected increases based on changing demographicsKelly G Paulson, Song Youn Park, Natalie A Vandeven, et al.Blood|February 8, 2008
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)John A Thompson, Richard I Fisher, Michael Leblanc, et al.Cancer|June 16, 2010
Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factorsRobert J Motzer, Bernard Escudier, Stephane Oudard, et al.The Oncologist|July 7, 2025
A mixed-method analysis of oncologist-patient communications about immune checkpoint inhibitors (COACH)Wenwen Chen, Julia Majovski, Shailender Bhatia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2008
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinomaJohn A Thompson, Brendan D Curti, Bruce G Redman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanomaSteven J O'Day, Michael B Atkins, Peter Boasberg, et al.Pageof 28